A new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus ...

The Chikungunya virus has been in the news lately as individuals who took the vaccine to prevent it were hospitalized. Many ...

More information: Rimjhim Agarwal et al, Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease, Nature Communications (2025 ...

The US Food and Drug Administration said Thursday that it has approved the first vaccine to prevent disease caused by the chikungunya virus. Chikungunya, a mosquito-borne disease whose name in the ...

A new study, published recently in Nature Communications , offers the first-ever map of which parts of Chikungunya virus trigger the ...

Chikungunya virus (CHIKV) causes an acute febrile disease characterized by severe arthralgia in the small joints. This arthralgia is highly debilitating and can be chronic.

Chikungunya virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humans. Cell Reports Medicine, 2025; 6 (5): 102134 DOI: 10.1016/j.xcrm.2025.102134; ...

The U.S. Food and Drug Administration on Thursday approved the first vaccine against chikungunya virus, a disease that is primarily transmitted to people through infected mosquito bites. The ...

The study focused on blood samples from CHIKV patients in Colombia and found that even six years after initial infection, 87% of patients still had CD4+ T cells that specifically recognized the virus.

LA JOLLA, CA—Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has been identified in more than 110 countries around the world. The virus typically causes flu-like symptoms, but it can ...

Most of the locally-acquired cases of chikungunya appear to be clustered around two towns near Marseille, Toulon and ...